-
Mashup Score: 3ARC 2022 Community Survey Results - 9 month(s) ago
Over 1200 responses were completed for the 2022 ARC Community Survey during April and May of that year. 79% of participants identified …
Source: arci.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Webinar: Cardiac & Neurological Approaches in ATTR Management - 10 month(s) ago
In this ARC TALKS webinar, Dr. Nativi-Nicolau and Dr. Elizabeth Mauricio will discuss the decision pathway in management of ATTR …
Source: arci.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📅 #ARCTALKS Webinar: July 31 Don't miss @lizmauricio23 and Jose Nativi-Nicolau, MD as they discuss decision pathways in the management of #ATTR #amyloidosis from the cardiac and neurological standpoint: https://t.co/X23hcu4VOz
-
-
Mashup Score: 0
–Â Â Highly statistically significant result observed on primary endpoint with a Win Ratio of 1.8 (p
Source: BridgeBio PharmaCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Great news from @BridgeBioPharma: they've announced "consistently positive results from phase 3 ATTRibute-CM study of acoramidis for patients with transthyretin #amyloid cardiomyopathy (#attr-cm)" https://t.co/2KXpGCSIxC
-
-
Mashup Score: 0Amyloidosis Forum 2023: ATTR Drug Development - 10 month(s) ago
Recorded and edited interviews for the “Patient Perspectives: Today’s Unmet Need” session at the 2023 Amyloidosis Forum meeting.
Source: YouTubeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Researchers, life science companies, & other #ATTR #amyloidosis HCPs: What's really important to patients and caregivers? For the #AmyloidosisForum we worked with @MathewMaurer to ask patients how the next phase of #drugdevelopment will impact their lives https://t.co/Jp151XzO7l
-
-
Mashup Score: 2Advancing ATTR Drug Development - 10 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We're delighted last week's #AmyloidosisForum delivered so many great conversations about the future of #ATTR #amyloidosis drug development. We're already hard at work turning those conversations into action! Watch the entire event yourself here: https://t.co/crQV0os656
-
-
Mashup Score: 2All 2023 Forum Patient Interviews - 11 month(s) ago
Recorded and edited interviews for the “Patient Perspectives: Today’s Unmet Need” session at the 2023 Amyloidosis Forum meeting.
Source: YouTubeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We're thankful to the #ATTR #amyloidosis patients willing to share their experience and perspectives today. We'll have the entire meeting recorded and posted to our site in the coming weeks. Until then, you can view our recorded patient interviews here: https://t.co/Jp151XzO7l
-
-
Mashup Score: 1
Welcome! You are invited to join a webinar: Amyloidosis Forum: Advancing Drug Development in ATTR in an Evolving Treatment Landscape. After registering, you will receive a confirmation email about joining the webinar.
Source: ZoomCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Kicking off the #AmyloidosisForum as Julian Gillmore, MD presents an overview of #ATTR #amyloidosis Join now: https://t.co/mzUX1G1TCN
-
-
Mashup Score: 6
Welcome! You are invited to join a webinar: Amyloidosis Forum: Advancing Drug Development in ATTR in an Evolving Treatment Landscape. After registering, you will receive a confirmation email about joining the webinar.
Source: ZoomCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🔬💊 Happening Now: The #AmyloidosisForum will consider how to effectively design #ATTR #amyloidosis trials as the first generation of drug approvals have reshaped the research landscape. Join us and 60+ speakers all day today: https://t.co/mzUX1G1TCN https://t.co/LQxBfG8hEY
-
-
Mashup Score: 3Advancing ATTR Drug Development - 11 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📆🔬💊 We're all set up for tomorrow's #AmyloidosisForum at FDA's White Oak campus (and online via Zoom). All day discussions around #ATTR #amyloidosis drug development. Don't miss out! Register now: https://t.co/R7suiCWCGW https://t.co/KDjkmYmnd4
-
-
Mashup Score: 1Advancing ATTR Drug Development - 11 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We're on our way to DC for tomorrow's #AmyloidosisForum. Can't wait to work with over 60 speakers and push #ATTR #amyloidosis drug development forward! https://t.co/R7suiCWCGW https://t.co/RqssmDmXZ6
-
Over 1200 #amyloidosis patients and caregivers participated in our 2022 Community Survey during April and May of last year. See what they had to share about their #AL #ATTR #AA and other amyloidosis journeys: https://t.co/lMV2pZxHyD